Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
In: Journal of Family Practice, Jg. 53 (2004-07-01), Heft 7, S. 570-572
Online
academicJournal
Zugriff:
Adjusted-dose warfarin remains the most efficacious antithrombotic regimen for the primary and secondary prevention of cardioembolic stroke in high-risk patients with nonvalvular atrial fibrillation. Aspiring therapy at a dose of 75 to 325 milligrams reduces the risk of stroke to a lesser degree and may be useful for low-risk patients with nonvalvular atrial fibrillation or patients at high risk for bleeding. Combination therapy with low fixed-dose warfarin and aspirin has not been shown to be superior to aspirin therapy alone. Moreover, this combination appears to be inferior to adjusted-dose warfarin. To date, no clinical trials have investigated the efficacy and safety of combining adjusted-dose warfarin and aspirin for the prevention of strokefrom nonvalvular atrial fibrillation.
Titel: |
Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
|
---|---|
Autor/in / Beteiligte Person: | Robertson, Sandy L. ; Mayer, Jill Byerly |
Link: | |
Zeitschrift: | Journal of Family Practice, Jg. 53 (2004-07-01), Heft 7, S. 570-572 |
Veröffentlichung: | 2004 |
Medientyp: | academicJournal |
ISSN: | 0094-3509 (print) |
Schlagwort: |
|
Sonstiges: |
|